A medical instrument in which an inorganic salt solid such as apatite into which a peptide hormone or the like is embedded is placed so that a metal or the like is coated therewith, in which the inorganic salt solid is provided by controlled delay co-precipitation or the like in an unstable supersaturated calcium phosphate solution, and the medical instrument is exposed to ionizing radiation at a dose sufficient for sterilization.

The present application is directed to a method of treating osteoarthritis, which includes obtaining a member of a transforming growth factor superfamily of proteins; obtaining a population of cultured mammalian cells that may contain vector encoding a gene, or a population of cultured connective tissue cells that do not contain any vector encoding a gene; and then transferring the protein and the connective tissue cells into an arthritic joint space of a mammalian host, such that the activity of the combination within the joint space results in regenerating connective tissue.

The present disclosure pertains to ionic polymer compositions, including semi- and fully interpenetrating polymer networks, methods of making such ionic polymer compositions, articles made from such ionic polymer compositions, and methods of making such articles and packaging for such articles.

A human amniotic fluid formulation has been developed for administration into a joint or associated soft tissue such as a tendon or ligament for treatment of pain, degeneration, or injury. The formulation is a sterile de-cellularized human amniotic fluid (D-HAF), devoid of amniotic stem cells and elements of micronized membrane or chorion particles, which has not been heat treated or treated with ethidium bromide. The formulation is optionally diluted, or concentrated, depending on the severity of the disorder or injury. Examples demonstrate efficacy in treatment of pain, disease, disorder, degeneration or injury of a joint or associated soft tissues.

A treatment method for zirconium alloy includes performing a surface layer oxidation and removal treatment on a surface layer of zirconium alloy. The surface layer oxidation and removal treatment comprises performing an oxidation treatment on the surface layer of the zirconium alloy to obtain an oxide surface layer, and then removing the oxide surface layer to expose a metal substrate. A method for fabricating a surface oxide ceramic layer of zirconium alloy and a material for a medical implant are also provided.

Provided are liposomes that encapsulate adenosine. The liposomes may be formed from sphingomyelin or a combination of sphingomyelin and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) or a combination of sphingomyelin and 1,2-dimyristoyl-sn-glycero-3-phosphorylglycerol (DMPG) or a combination of sphingomyelin, DMPG, and DMPC. The liposomes encapsulating adenosine may be used to induce cartilage regeneration, treat osteoarthritis, alleviate joint pain, and/or slow, arrest, and/or reverse progressive structural tissue damage associated with osteoarthritis or treat osteoarthritis, rheumatoid arthritis, acute gouty arthritis, and/or synovitis. The liposomes may release adenosine for up to two weeks.

The present application relates to a freeze-dried polymer composition containing chitosan and at least one lyoprotectant, a process for preparing a freeze-dried composition containing chitosan and at least one lyoprotectant and the use of a reconstituted freeze-dried chitosan composition to prepare implants for tissue repair.

The invention discloses a preparation method and application of an oxidized ceramic layer on the surface of zirconium and zirconium alloy. The method comprises the following steps: reducing the roughness of a target area to 0.01 μm or less, performing oxidation treatment in an oxidizing gas atmosphere, and replacing the oxidizing gas with inactive gas. According to the technical solution provided in the present application, the surface roughness is controlled before oxidation treatment, so that the surface roughness after oxidation treatment can satisfy the use requirements; and the inert gas replacement after surface oxidation treatment avoids the removal of a film layer with poor performance formed during the cooling process, thereby completely avoiding the need for later polishing treatment, maintaining the integrity and uniformity of the oxidized ceramic layer, and guaranteeing the protective performance.

The present application relates to a use for cartilage regeneration and/or use for osteoarthritis treatment of a mesenchymal stem cell expressing TSG-6 protein. The present application provides a composition for cartilage regeneration and a pharmaceutical composition for osteoarthritis treatment, comprising a mesenchymal stem cell expressing TSG-6 protein as an active ingredient. The composition for cartilage regeneration and/or the pharmaceutical composition for osteoarthritis treatment provided by the present application can increase collagen expression of cartilage cells, reduce inflammation, and restore the cartilage structure.

An orthopedic prosthesis includes a head which internally accommodates the major motion of a patient, e.g., during walking, thereby reducing wear against a cup or liner. A neck may be utilized which rotates within the distal member about an axis aligned with the major motion of the patient. The orthopedic prosthesis may also include a sacrificial anode, a seal made of natural fibers, and utilize lubricant made of honey.